newsfilter
← Latest News
FDA Approved Drugs·

Approval of Juvmo, Nda #220415 (Type 1 - New Molecular Entity)

Approval Date: 09/25/2026; Drug Name: Juvmo, Nda #220415; Active Ingredients: TAVAPADON; Company: Abbvie Inc; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 220415

Company
ABBVIE INC
Keywords
ABBVIE INC